0
Fibrocell Science Inc
- 51-200 Employees
- Based in Exton, Pennsylvania
Fibrocell Science, Inc., an autologous cell therapy company, focuses on developing treatments for skin and connective tissue diseases with unmet medical needs. The company, through its proprietary autologous fibroblast technology, develops azficel-T, which is in Phase II clinical trials for the treatment of vocal cord scarring and restrictive burn scarring.
Fibrocell Science Inc
Most Recent Responsibility Report
MOST RECENT
Shipping Information
Request Information
Fibrocell Science Inc does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
Our service enables potential investors to review the most recent and archived Fibrocell Science Inc Sustainability Report, Fibrocell Science Inc Corporate Social Responsibility Report, Fibrocell Science Inc CSR Report, Fibrocell Science Inc Corporate Responsibility, Fibrocell Science Inc CR Report, Fibrocell Science Inc Citizenship Report, Fibrocell Science Inc ESG Report, and Fibrocell Science Inc Environmental Report online.